نتایج جستجو برای: acting antiviral

تعداد نتایج: 108524  

Journal: :Advances in Digestive Medicine 2022

Hepatitis C virus (HCV) infection is an important public health problem, causing significant morbidity and mortality worldwide. The prevalence of HCV infections especially high among people who inject drugs (PWID). efficacy direct-acting antiviral (DAA) therapy was evaluated herein. During 2019-2021, a total 321 cases received full course DAA completed 12-week follow-up observation were studied...

2017
Sandra Phillips Sameer Mistry Antonio Riva Helen Cooksley Tanya Hadzhiolova-Lebeau Slava Plavova Krum Katzarov Marieta Simonova Stephan Zeuzem Clive Woffendin Pei-Jer Chen Cheng-Yuan Peng Ting-Tsung Chang Stefan Lueth Robert De Knegt Moon-Seok Choi Heiner Wedemeyer Michael Dao Chang-Wook Kim Heng-Chen Chu Megan Wind-Rotolo Roger Williams Elizabeth Cooney Shilpa Chokshi

IFN-lambda (IFNλ) is a member of the type III IFN family and is reported to possess anti-pathogen, anti-cancer, and immunomodulatory properties; however, there are limited data regarding its impact on host immune responses in vivo. We performed longitudinal and comprehensive immunosurveillance to assess the ability of pegylated (peg)-IFNλ to augment antiviral host immunity as part of a clinical...

2015
Michelle Goritzka Spyridon Makris Fahima Kausar Lydia R. Durant Catherine Pereira Yutaro Kumagai Fiona J. Culley Matthias Mack Shizuo Akira Cecilia Johansson

Type I interferons (IFNs) are important for host defense from viral infections, acting to restrict viral production in infected cells and to promote antiviral immune responses. However, the type I IFN system has also been associated with severe lung inflammatory disease in response to respiratory syncytial virus (RSV). Which cells produce type I IFNs upon RSV infection and how this directs immu...

2015
Syed Tasleem Gagan K Sood

The link between chronic hepatitis C virus (HCV) infection and a subset of B-cell non-Hodgkin lymphomas (B-NHL) is strongly supported by epidemiological studies. Evidence demonstrating complete regression of lymphoma after antiviral treatments suggests possible chronic antigenic stimulation for the origin of B-NHL and provides evidence for a virus-mediated lymphomagenesis. B-NHL is a heterogene...

Journal: :Frontiers in bioscience 2011
Stevan A Gonzalez Emmet B Keeffe

Viral hepatitis is a major cause of chronic liver disease, liver failure, and hepatocellular carcinoma worldwide, resulting in significant morbidity and mortality. New insights into the pathogenesis and molecular biology of hepatitis viruses have led to the discovery of novel antiviral agents. Likewise, a greater understanding of the natural history of chronic infection, predictors of disease p...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2011
Margaret Robinson Yang Tian William E Delaney Andrew E Greenstein

Clinical trials of direct-acting antiviral agents in patients chronically infected with hepatitis C virus (HCV) have demonstrated that viral resistance is detected rapidly during monotherapy. In patients, HCV does not exist as a single, genetically homogenous virus but rather as a population of variants termed "quasispecies." Preexisting variants resistant to specific antiviral drugs, overlooke...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید